LRRK2 and Parkinson disease: Owing to insufficient reliable olfactory data in the QSBB series, we were unable to make comparisons; however, to detect anosmia in only 51% of patients with mutations in LRRK2 is unexpectedly low when olfactory dysfunction is reported in 80–100% of patients with idiopathic PD.8, 24